Author:
Liu Xiaohua,Yang Hao,Liu Yan,Jiao Yingfu,Yang Liqun,Wang Xiangrui,Yu Weifeng,Su Diansan,Tian Jie
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Pathology and Forensic Medicine
Reference39 articles.
1. Wawrocki S, Druszczynska M, Kowalewicz-Kulbat M, Rudnicka W. Interleukin 18 (IL-18) as a target for immune intervention. Acta Biochim Pol. 2016;63:59–63.
2. Boraschi D, Italiani P, Weil S, Martin MU. The family of the interleukin-1 receptors. Immunol Rev. 2018;281:197–232.
3. Kaplanski G. Interleukin-18: biological properties and role in disease pathogenesis. Immunol Rev. 2018;281:138–53.
4. Yamada T, Aoyama-Ishikawa M, Yamashita H, Fujiwara M, Usami M, Ueda T, et al. IL18 production and IL18 promoter polymorphisms correlate with mortality in ICU patients. In Vivo. 2014;28:391–6.
5. Liu X, Pan Z, Su D, Yang Z, Zheng B, Wang X, et al. Remifentanil ameliorates liver ischemia-reperfusion injury through inhibition of interleukin-18 signaling. Transplantation. 2015;99:2109–17.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献